<article><a href="http://www.voxelcloud.io" target="_blank" rel="noopener">VoxelCloud</a>, a medical artificial intelligence startup, has closed $15 million in Series A+ funding led by Chinese Internet major <a href="http://dealstreetasia.com/tag/tencent" target="_blank" rel="noopener">Tencent Holdings Ltd, </a>and its existing investors including <a href="http://dealstreetasia.cm/tag/sequoia-capital" target="_blank" rel="noopener">Sequoia Capital</a> and <a href="https://www.bloomberg.com/research/stocks/private/snapshot.asp?privcapId=2013832" target="_blank" rel="noopener">NewMargin Ventures</a>.</article>

<a href="http://www.voxelcloud.io" target="_blank" rel="noopener">VoxelCloud</a>, a medical artificial intelligence startup, has closed $15 million in Series A+ funding led by Chinese Internet major <a href="http://dealstreetasia.com/tag/tencent" target="_blank" rel="noopener">Tencent Holdings Ltd, </a>and its existing investors including <a href="http://dealstreetasia.cm/tag/sequoia-capital" target="_blank" rel="noopener">Sequoia Capital</a> and <a href="https://www.bloomberg.com/research/stocks/private/snapshot.asp?privcapId=2013832" target="_blank" rel="noopener">NewMargin Ventures</a>.
VoxelCloud plans to use the funds from this latest funding round to expand its AI-assisted medical solutions beyond hospitals, as well as to promote innovations in medical AI technology.
Based in Los Angeles, the startup venture utilises artificial intelligence (AI) and cloud-computing technologies to provide automated medical image analysis and clinical decision support for medical practitioners. In May 2017, VoxelCloud closed its $8 million A series from Sequoia Capital. The venture also maintains offices in Shanghai and Suzhou.
According to VoxelCloud CEO and co-founder, Dr. Xiaowei Ding, VoxelCloud has developed products that bring AI to healthcare for improved clinical workflow. Diseases covered include coronary heart disease, lung cancer screening and retinal diseases.
“Those three product lines have been applied by over 50 hospitals in China and in the US. Since they were applied, they have helped doctors in diagnosing over 50,000 patients with chest diseases, over 50,000 patients with heart disease patients and over 100,000 patients with retinal diseases.” Said Dr. Ding.
VoxelCloud’s CT Image Analysis product line has obtained FDA and CE approval for clinical uses. In China, VoxelCloud has also submitted five products for CFDA approval, and some of the products are expected to be cleared by the end of this year.
As for the future, Dr. Ding believes AI in medicine should go beyond hospitals and be applied in various medical scenarios, with the aim being to provide access to what he terms &#8220;accessible diagnosis&#8221;.. We believe AI has enabled us to provide more accessible, accurate and personalized medical solutions for doctors and patients. So other than developing products to assist existing clinical examinations, we are also developing products that can go beyond hospitals and benefit more patients.” Said
Dr Ding elaborated: &#8220;We believe AI has enabled us to provide more accessible, accurate and personalized medical solutions for doctors and patients. So other than developing products to assist existing clinical examinations, we are also developing products that can go beyond hospitals and benefit more patients.”
Tencent is the second highest-valued tech company in Asia and has been boosting its efforts in the medical AI space; it has established its own AI laboratory and released its own AI-assisted medical product this August for the early screening oesophagal cancer.
Also Read:
<a href="https://www.dealstreetasia.com/stories/tencent-backed-meituan-said-close-3-billion-plus-funding-83074/">China: Tencent-backed Meituan close to raising more than $3b in funding</a>
<a href="https://www.dealstreetasia.com/stories/tencent-take-5-percent-stake-investment-bank-cicc-367-million-82719/">Tencent to pick 5% stake in China investment bank CICC for $367m</a>
<a href="https://www.dealstreetasia.com/stories/tencent-guangzhou-auto-agree-collaborate-connected-cars-82601/">Tencent, Guangzhou Auto agree to collaborate on connected cars</a>

Medical AI startup VoxelCloud, which develops AI-assisted medical imaging, has closed a $15 million Series A+ investment from China's Tencent Holdings.

Tencent leads $15m Series A+ in VoxelCloud

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

Tencent leads $15m Series A+ in VoxelCloud

Start your deal-making journey now!

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief